PPARGC1A and obesity disorder: However, Morselli et al. demonstrated that reduced hypothalamic PGC-1α, targeting estrogens and estrogen receptor α (ERα), contributed to hypothalamic inflammation and obesity progress in response to HFD-induced palmitic acid (PA) accumulation in the brain in a sex-specific manner [35].